BVI Medical has appointed Andrew Chang as chief commercial officer. In this newly established role, Chang will lead the company’s Global Sales, Global Marketing, and Commercial Excellence teams and will report directly to President/CEO Shervin Korangy.

Chang began his career in finance and early-stage business roles before transitioning into the ophthalmic space, where he held progressive commercial leadership positions at ISTA Pharmaceuticals and later Bausch + Lomb. During his time at ISTA, he helped drive the successful introduction of multiple ophthalmic pharmaceutical products. Following the acquisition of ISTA by Bausch + Lomb, he took on broader responsibilities at OptiMedica, which sold to Abbott Medical Optics shortly after. Eventually he served as general manager and senior vice president for Bausch + Lomb Surgical, overseeing U.S. sales, marketing, operations, and business development.

Chang later joined ZEISS Medical Technology, where he served as president of Carl Zeiss Meditec USA Inc. and head of Global Sales for Ophthalmic Devices. In this role, he led global commercial strategy and market execution in diagnostic and surgical technologies, playing a key role in expanding ZEISS’s global footprint and driving sustained commercial growth.

Beyond his executive leadership roles, Chang is a passionate advocate for innovation in ophthalmology. He currently serves on industry and advisory boards like the ASCRS Foundation, the Ophthalmology Foundation, Medical Device Manufacturers Association (MDMA), CEDARS/ASPENS Industry Committee, AECOS Executive Committee, Ophthalmic World Leaders (OWL), and EyeSustain, and is a founding member of the Vanguard Ophthalmology Society. In the past he served on the boards of MicroOptx, FCI Ophthalmics Inc./FCI SAS (assuming the presidency too), and American Glaucoma Society Foundation.

Chang earned his bachelor of science degree in management from Rutgers University – Newark

BVI is a diversified global ophthalmic device company that delivers solutions for advancing eye surgery and improving patients’ vision. With nine decades of developing leading products and solutions, BVI partners with ophthalmic surgeons to improve patients’ vision. The company supports surgical teams in more than 90 countries worldwide, either directly or through its distribution network.